Myofascial pain in patients with postthoracotomy pain syndrome*1

Hamada, Hiroshi; Moriwaki, Katsuyuki; Shiroyama, Kazuhisa; Tanaka, Hiroyuki; Kawamoto, Masashi; Yuge, Osafumi

doi:10.1016/s1098-7339(00)90016-6

Cited by 15 publications

(4 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Hamada, et al12 documented a case series of 27 patients with post-thoracotomy pain, which is often assumed to be neuropathic in origin, and found the primary source of pain to be MTrPs in 67% of the patients. The authors commented that the existence of MTrPs significantly increased the rate of success after treatment.…”

Section: Discussionmentioning

confidence: 99%

Application of Ultrasound-Guided Trigger Point Injection for Myofascial Trigger Points in the Subscapularis and Pectoralis Muscles to Post-Mastectomy Patients: A Pilot Study

Shin

Kim

et al. 2014

Yonsei Med J

View full text Add to dashboard Cite

PurposeTo investigate the therapeutic effectiveness of ultrasound (US)-guided trigger point injection for myofascial trigger points (MTrPs) in the internal rotator muscles of the shoulder in post-mastectomy patients.Materials and MethodsThis pilot study was a non-controlled, prospective, clinical trial. Nineteen post-mastectomy patients with a diagnosis of at least one active MTrP in the subscapularis and/or pectoralis muscles were included. We performed trigger point injections into the subscapularis muscle deep behind the scapula as well as the pectoralis muscle for diagnostic and therapeutic purpose by the newly developed US-guided method.ResultsVisual analogue scale and range of motion of the shoulder for external rotation and of abduction showed significant improvement immediately after the first injection and 3 months after the last injection compared with baseline (p<0.05 for both). Duration from onset to surgery and duration of myofascial pain syndrome in the good responder group were significantly shorter than in the bad responder group (p<0.05). Patients did not report any complications related to the procedure or serious adverse events attributable to the treatment.ConclusionIn post-mastectomy patients with shoulder pain, US-guided trigger point injections of the subscapularis and/or pectoralis muscles are effective for both diagnosis and treatment when the cause of shoulder pain is suspected to originate from active MTrPs in these muscles, particularly, the subscapularis.

show abstract

Section: Discussionmentioning

confidence: 99%

Application of Ultrasound-Guided Trigger Point Injection for Myofascial Trigger Points in the Subscapularis and Pectoralis Muscles to Post-Mastectomy Patients: A Pilot Study

Shin

Kim

et al. 2014

Yonsei Med J

View full text Add to dashboard Cite

show abstract

“…Similarly, a high prevalence of MPS was observed in individuals with spinal cord injury [ 65 ], brachial plexus injury [ 66 ], trigeminal neuralgia [ 67 ], diabetic peripheral neuropathy [ 68 ], and post-thoracotomy pain syndrome [ 69 ].…”

Section: Methodsmentioning

confidence: 99%

The Case for Comorbid Myofascial Pain—A Qualitative Review

Vulfsons

Minerbi

2020

IJERPH

View full text Add to dashboard Cite

Myofascial pain syndrome is widely considered to be among the most prevalent pain conditions, both in the community and in specialized pain clinics. While myofascial pain often arises in otherwise healthy individuals, evidence is mounting that its prevalence may be even higher in individuals with various comorbidities. Comorbid myofascial pain has been observed in a wide variety of medical conditions, including malignant tumors, osteoarthritis, neurological conditions, and mental health conditions. Here, we review the evidence of comorbid myofascial pain and discuss the diagnostic and therapeutic implications of its recognition.

show abstract

“…Sensory loss and allodynia are usually present as well. The exact mechanism for the pathogenesis of PTPS remains unclear and is probably a combination of neuropathic and myofascial pain (MFP) ( 18 ). Genetics, age, gender, preoperative stress, and perioperative pain have been identified as predisposition factors for PTPS.…”

Section: Clinical Pain Syndromes In Patients With Lung Cancermentioning

confidence: 99%

Interventional Analgesic Management of Lung Cancer Pain

2017

View full text Add to dashboard Cite

Lung cancer is one of the four most prevalent cancers worldwide. Comprehensive patient care includes not only adherence to clinical guidelines to control and when possible cure the disease but also appropriate symptom control. Pain is one of the most prevalent symptoms in patients diagnosed with lung cancer; it can arise from local invasion of chest structures or metastatic disease invading bones, nerves, or other anatomical structures potentially painful. Pain can also be a consequence of therapeutic approaches like surgery, chemotherapy, or radiotherapy. Conventional medical management of cancer pain includes prescription of opioids and coadjuvants at doses sufficient to control the symptoms without causing severe drug effects. When an adequate pharmacological medical management fails to provide satisfactory analgesia or when it causes limiting side effects, interventional cancer pain techniques may be considered. Interventional pain management is devoted to the use of invasive techniques such as joint injections, nerve blocks and/or neurolysis, neuromodulation, and cement augmentation techniques to provide diagnosis and treatment of pain syndromes resistant to conventional medical management. Advantages of interventional approaches include better analgesic outcomes without experiencing drug-related side effects and potential for opioid reduction thus avoiding central side effects. This review will describe various pain syndromes frequently described in lung cancer patients and those interventional techniques potentially indicated for those cases.

show abstract

Myofascial pain in patients with postthoracotomy pain syndrome*1

Cited by 15 publications

References 10 publications

Application of Ultrasound-Guided Trigger Point Injection for Myofascial Trigger Points in the Subscapularis and Pectoralis Muscles to Post-Mastectomy Patients: A Pilot Study

Application of Ultrasound-Guided Trigger Point Injection for Myofascial Trigger Points in the Subscapularis and Pectoralis Muscles to Post-Mastectomy Patients: A Pilot Study

The Case for Comorbid Myofascial Pain—A Qualitative Review

Interventional Analgesic Management of Lung Cancer Pain

Contact Info

Product

Resources

About